Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) CEO Thomas David Hull III sold 213 shares of the company’s stock in a transaction that occurred on Friday, March 21st. The shares were sold at an average price of $48.53, for a total transaction of $10,336.89. Following the transaction, the chief executive officer now owns 40,916 shares in the company, valued at $1,985,653.48. The trade was a 0.52 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Monday, March 24th, Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.63, for a total transaction of $136,890.00.
- On Friday, January 10th, Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock. The stock was sold at an average price of $60.08, for a total value of $82,189.44.
- On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $63.01, for a total transaction of $126,020.00.
Kewaunee Scientific Trading Down 3.3 %
KEQU traded down $1.54 during mid-day trading on Monday, hitting $44.96. 43,557 shares of the stock were exchanged, compared to its average volume of 22,493. The company has a market cap of $128.36 million, a PE ratio of 7.13 and a beta of 0.71. Kewaunee Scientific Co. has a 1-year low of $30.82 and a 1-year high of $71.33. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The firm’s fifty day moving average is $57.46 and its two-hundred day moving average is $47.68.
Institutional Trading of Kewaunee Scientific
A number of institutional investors have recently bought and sold shares of KEQU. Minerva Advisors LLC raised its stake in Kewaunee Scientific by 4.1% during the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock worth $6,668,000 after acquiring an additional 4,311 shares in the last quarter. Invesco Ltd. acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at $6,545,000. De Lisle Partners LLP boosted its stake in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after purchasing an additional 11,511 shares during the period. American Century Companies Inc. grew its position in Kewaunee Scientific by 18.0% during the 4th quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock worth $2,122,000 after purchasing an additional 5,221 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC increased its stake in Kewaunee Scientific by 3.3% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after purchasing an additional 891 shares during the period. 32.69% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com lowered shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.
View Our Latest Report on KEQU
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- Canada Bond Market Holiday: How to Invest and Trade
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Expert Stock Trading Psychology Tips
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.